Skip to main content

Table 2 The details and characteristics of the 16 included studies divided into severe and non-severe groups

From: What can the neurological manifestations of COVID-19 tell us: a meta-analysis

Study Severe Non-severe
Case Headache Dizziness Seizure Myalgia Smell impairment Taste dysfunction Case Headache Dizziness Seizure Myalgia Smell impairment Taste dysfunction
Ling Mao et al. [8] 88 15 17 1 / 3 3 126 13 19 / / 8 9
Antoine Guilmot et al. [42] 9 / / 1 / / / 6 / / 1 / 2 /
Nitesh Gupta et al. [68] 32 13 / / / / / 168 9 / / / / /
François Lersy et al. [84] 47 1 / 3 / / / 11 2 / 3 / / /
Rajesh Benny et al. [85] 47 8 / 9 / 7 2 53 13 / 9 / 3 6
Daniel Schonfeld et al. [94] 5652 1168 / 60 1002 380 320 41,703 12,517 / 223 9572 5893 4508
Caizheng Yu et al. [110] 864 / / / 31 / / 799 / / / 26 / /
Shenae Samuels et al. [111] 147 21 / / 30 / / 346 26 / 3 86 / /
Eric M. Liotta et al. [113] 134 43 40 / 56 11 17 375 149 111 4 172 47 64
Carlos Manuel Romero-Sánchez et al. [129] 329 38 17 4 44 9 13 512 81 34 2 101 32 39
Xudong He et al. [132] 23 3 4 / 8 / / 54 1 5 / 10 / /
Mehran Ghaffari et al. [138] 233 60 22 7 101 42 41 128 49 12 3 73 27 28
Man Amanat et al. [140] 299 24 29 / 75 / / 574 86 75 / 142 / /
Egehan Salepci et al. [169] 45 11 4 / / 6 12 178 48 1 / / 65 65
J. Zhang et al. [170] 409 13 21 / 30 / / 254 7 2 / 33 / /
Altunisik E et al.(180) 11 4 2 / / / / 40 5 5 / / 3 3
  1. Of all the included literatures, 16 studies grouped neurologic features based on COVID-19 severity. We focused on five neurologic manifestations of headache,dizziness,seizure,myalgia, smell impairment and taste dysfunction